Comments

VYNE Therapeutics

Q: What sector and industry does VYNE Therapeutics (VYNE) operate in?

VYNE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

VYNENASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$2.74

0.041.48%

At close: -

$2.62

-0.12-4.38%

After Hours: Feb 21, 8:00 AM EDT

VYNE Therapeutics (VYNE) Forecast

News Earnings VYNE Therapeutics (VYNE) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Want to View Edge Rankings?

Unlock The Hidden Results With Your Benzinga Account Now.

Get Started

VYNE Therapeutics (NASDAQ:VYNE) Stock Quotes, Forecast and News Summary

VYNE Therapeutics Stock (NASDAQ: VYNE) stock price, news, charts, stock research, profile.

Open	$2.75
Close	$2.74
Volume / Avg.	67.72K / 105.61K
Day Range	$2.62 - $2.94
52 Wk Range	1.57 - 4.30
Market Cap	$38.65M
P/E Ratio	0.82
Dividend Yield	-
Exchange	NASDAQ
RSI	56
Short Interest	0.84%
Days to Cover	1.28

Recent News

Top 4 Health Care Stocks That May Rocket Higher In Q1

The most oversold stocks in the health care presents an opportunity to buy into undervalued companies.

Avi Kapoor

Why Richardson Electronics Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket

Shares of Richardson Electronics, Ltd. (NASDAQ: RELL) fell sharply in today’s pre-market trading after the company posted weaker-than-expected results for its second quarter.

Avi Kapoor

Dow Surges Over 500 Points; Western Digital Announces Plan To Split Into Two Companies

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 500 points on Monday. The Dow traded up 1.67% to 32,959.68 while the NASDAQ rose 1.25% to 12,800.95. The S&P 500 also rose, gaining, 1.23% to 4,167.91.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep 24

Nov 24

Dec 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.75
Close	$2.74
Volume / Avg.	67.72K / 105.61K
Day Range	$2.62 - $2.94
52 Wk Range	1.57 - 4.30
Market Cap	$38.65M
P/E Ratio	0.82
Dividend Yield	-
Exchange	NASDAQ
RSI	56
Short Interest	0.84%
Days to Cover	1.28

About VYNE Therapeutics Inc

Sector

Health Care

Industry

Pharmaceuticals

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative a...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy VYNE Therapeutics (VYNE) stock?

You can purchase shares of VYNE Therapeutics (NASDAQ:VYNE) through any online brokerage.

View our list of the best stock brokerages

Who are VYNE Therapeutics (VYNE) competitors?

Other companies in VYNE Therapeutics’s space includes: Iterum Therapeutics (NASDAQ:ITRM), SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC), Rani Therapeutics Hldgs (NASDAQ:RANI) and Cara Therapeutics (NASDAQ:CARA).

What is the forecast, or price target, for VYNE Therapeutics (VYNE) stock?

VYNE Therapeutics has a consensus price target of $7.58.

What is the current price for VYNE Therapeutics (VYNE)?

The stock price for VYNE Therapeutics (NASDAQ: VYNE) is $2.62 last updated February 21, 2025 at 8:00 AM EST.

Does VYNE Therapeutics (VYNE) pay a dividend?

There are no upcoming dividends for VYNE Therapeutics.

When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?

VYNE Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is VYNE Therapeutics (VYNE) going to split?

There is no upcoming split for VYNE Therapeutics.

What sector and industry does VYNE Therapeutics (VYNE) operate in?

VYNE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.